… A particularly interesting case report discussed the intrauterine onset of a fibular (peroneal) …
In this case report, the authors discuss other cases in which onset predated the delivery, as …

… , individual case reports will not represent the range of … as the concomitant use of other
drugs, or the presence of natural disease. Consequently, when a substance is detected in a case, …

… Amiodarone, a highly effective drug used in the treatment of … to those observed in perhexiline
or chloroquine neuropathy) … can be masked by the concomitant presence of signs of central …

… A clear example of this is verapamil, a potent hERG blocker that does not cause QT
prolongation, likely due to its concomitant blockade of the calcium current. Amiodarone is an …

… Here, we report an integrated pharmacogenomic analysis of 100 patient-derived GBM cell
cultures from the human glioma cell culture (HGCC) cohort. Exploring 1,544 drugs, we find …

… , case series, and … concomitantly and after treatment for CIPN resulting from cisplatin,
oxaliplatin, paclitaxel, and vincristine, without any interference with the antitumor activity of the drugs…

… , treatment includes aetiological and symptomatic measures. In this chapter we aim to cover
… epidemiology, aetiology, signs and symptoms, evaluation, diagnosis and treatment options. …

… - Avoid Concomitant Use: There are no known interactions where it is recommended to
avoid concomitant use. - Increased Effect/Toxicity: There are no known significant interactions …

… Due to the heterogeneity of NAFLD presentations and the multifactorial etiology of the
disease, clinical trials for NAFLD treatment are testing a wide range of interventions and drugs, …

… The most commonly encountered form of phenoconversion in clinical practice results from
the use of concomitant medications that can inhibit or induce the CYP enzymes, resulting in a …